Medical myth: in the past aspirin was thought to be a relatively safe addition to chronic coronary syndrome patients’ drug regime post stent.
Reality: In late 2025 french doctors abandoned a clinical trial that examined the benefits of aspirin in addition to other blood thinners in CCS patients after a stent fitting, becuase it would be unethical to continue. They found that aspirin increased patients risk of an adverse event by 30% within two years.
Talk to your doctor before making any changes to your drug regimine. This story is for informational purposes only and is not medical advice.
Learn more here:
Lemesle G, Didier R, Steg PG, et al. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. New England Journal of Medicine. 2025;393(16):1578-1588. doi:10.1056/NEJMoa2507532
